Recent News

• 02.05.2026 - Anaptys Announces Participation at Upcoming Investor Conferences
• 02.05.2026 - Anaptys Announces Participation at Upcoming Investor Conferences
• 01.08.2026 - Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
• 01.08.2026 - Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary

Recent Filings

• 01.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.16.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.15.2026 - 144 Report of proposed sale of securities
• 01.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.09.2026 - 144 Report of proposed sale of securities
• 01.09.2026 - 144 Report of proposed sale of securities
• 01.09.2026 - 8-K Current report
• 01.09.2026 - EX-99.1 EX-99.1
• 01.09.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.09.2026 - 144 Report of proposed sale of securities